CD19 and CD22-targeting CAR-T cells
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for CD19 and CD22-targeting CAR-T cells, covering 2021-01-22 to 2023-12-29. Get the full timeline:
Most recent: Clinical Trial Update: Targeting CD19 and CD22 CAR-T Cells Immunotherapy in Patients With Relapsed or Refractory B Cell Lymphoma [Phase 1, Phase 2]